Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for skin picking in children and young adults with Prader-Willi syndrome
2019-000735-61Phase 2Active
- Sponsor
- Dutch Growth Research Foundation
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of acetylcysteine in Prader-Willi syndrome (PWS) and Excoriation disorder (SPD) (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoint: Primary endpoint: change in number and size of skin picking lesions. Started Aug 2020; status: active.
02
Drugs
acetylcysteine
03
Conditions
Prader-Willi syndrome (PWS)Excoriation disorder (SPD)
Beyond the preview
Go deeper on 2019-000735-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000735-61.